To uncover the molecular underpinnings of the impact of Osthole on prostate cancer, this study utilized a western blot assay to methodically evaluate the expression levels of PRLR, as well as the expression and phosphorylation levels of JAK2 and STAT3 in the 22RV1 cell line. The gene discussed is JAK2; the disease is prostate carcinoma.